At Web Summit 2024 we had a quick but memorable chat at the Sincrolab stand with Beatriz Santos Cabezon (Customer Success). That conversation sent us down a rabbit hole—because Sincrolab isn’t “just another brain-training app.” It’s a clinically validated, AI-powered digital therapeutic (DTx) designed to improve attention and inhibitory control for kids with ADHD—delivered as prescribed, structured gameplay. In other words: real therapy, not just games. Learn more on their site: sincrolab.es.

🧩 The Problem Sincrolab Tackles

ADHD-C (combined type) presents as inattention, impulsivity, and hyperactivity, often disrupting learning and family life. Traditional therapy can be hard to access and maintain—weekly sessions reduce continuity, motivation dips, and adherence wanes between visits. Sincrolab targets that gap by bringing evidence-based cognitive training home, in 15-minute sessions several times per week—aligned with the therapist’s plan and the child’s cognitive profile.

🎮 The Solution: Prescription-Grade Gameplay

Sincrolab’s product personalizes “game-like” tasks that train attention, working memory, and inhibitory control. The AI engine adapts difficulty in real time, ensuring each child gets the right “dose” and progression—prescribed and time-limited by clinicians. Their consumer-facing brand, Sea of Heroes: New World, is CE-marked (Class IIa) and the company is ISO 13485 certified—strong signals for medical-device rigor.

Evidence highlights

• Randomized Controlled Trial (RCT): Improvements in inhibitory control and visuospatial working memory; neurophysiological changes (alpha-band power) observed via MEG.
• Product evidence page: Reported clinically significant shifts on EDAH symptom scales after 3 months of treatment.
• Clinical momentum: Sincrolab has been profiled by partners and media for its AI-plus-gamification approach to ADHD.
  

🧠 What Makes Sincrolab Stand Out

• Clinical validation first: Peer-reviewed data and a registered RCT (ISRCTN71041318) set it apart from generic “brain games.”
• Medical-device mindset: CE Class IIa + ISO 13485 bring quality management and safety to the fore.
• Therapist-centered workflow: Clinicians assess cognitive profiles, tailor “dosage,” and monitor progress remotely.
• AI-driven personalization: Dynamic adaptation across 14 games / ~200 modes / ~1,500 stimuli keeps training engaging and targeted.
• Ecosystem credibility: Collaboration announcements from pharma partners reinforce traction.
  
  
  

🤝 YOUR R&D × Sincrolab: Where We Can Collaborate

As an AI & software engineering partner focused on HealthTech, YOUR R&D helps product teams scale regulated digital health products from lab to market. Here’s how we see high-value collaboration with Sincrolab:

SaMD, QMS & Compliance Acceleration

• Regulatory playbooks: MDR/CE support for iterative updates (Class IIa lifecycle), design history files, and CAPA workflows.
• Automation: CI/CD pipelines that preserve QMS traceability (requirements ↔ tests ↔ risk).
• Clinical ops tech: Data capture scaffolding for post-market surveillance and multi-site studies.
  

Personalization & Data Science

• Adaptive algorithms: Co-create next-gen personalization (context-aware “dosing,” engagement risk flags, and RL-based progression).
• Signal pipelines: Privacy-preserving analytics to correlate gameplay telemetry with symptom scales and neurophys markers (e.g., MEG/EEG).
• A/B platforms: Rapidly compare task variants or difficulty curves while maintaining clinical integrity.
  

Product & Growth Engineering

• Performance & reliability: Mobile optimizations for low-end devices and flaky home networks.
• Engagement loops: Ethical engagement (notifications, parent insights) aligned with clinician-set “dosages.”
• Co-marketing content: Evidence-led explainers for clinicians and caregivers to boost adoption without overclaiming.
  

vIf you’re exploring a development sprint or a proof-of-concept on new ADHD comorbidities (e.g., dyslexia-adjacent working memory challenges) or age-expansion to adults (Sincrolab also has an adults app), we’d love to brainstorm a joint pilot.

🧭 Who’s Behind Sincrolab?

Sincrolab blends neuroscience, clinical practice, and product rigor: Ignacio de Ramón Burgos (CEO), Alfonso Hernández-Maureta (CFO), Manuel S. Lemos (CTO), Marta Torres Díaz (VP Growth), and Beatriz Santos (Customer Success) are among the public faces you’ll find online.

👉 Explore our focus and recent work at YOUR R&D and browse our HealthTech insights.

#HealthTech #DigitalTherapeutics #ADHD #AIinHealthcare #SaMD #CognitiveTraining #MedTechInnovation #YOURRND